TheEdgeResearch
Home / Stocks / MVMDF

More Life Company Corp. (MVMDF)

OTC Healthcare Biotechnology
$0.04 ▲ +7.60%
Market Cap
$12.9M
Sector
Healthcare
Industry
Biotechnology
Beta
-1.37
52-Wk Range
0.0074-0.0887
CEO
Dennis Hancock
Country
CA
Currency
USD

More Life Company Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Concord, ON, CA. The stock last traded at $0.04, up 7.60% on the session, giving a market capitalisation of $12.9M. On trailing twelve-month figures it carries a trailing P/E of -3.61, a net margin of -5330.0%. Its beta of -1.37 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.61
Price / Sales
228.50
Price / Book
8.93
EV / EBITDA
-5.89
Gross margin
52.9%
Operating margin
-3604.3%
Net margin
-5330.0%
Return on equity
—
Debt / equity
0.00
Current ratio
16.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2020-05-19
Headquarters
Concord, ON, CA
About More Life Company Corp.

The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.

More research on MVMDF
MVMDF technical analysis MVMDF TheEdge Score Compare against peers
Open full interactive analysis & DCF →